SPARCLIFE

Serial Number 97261612
Registration 7065692
700

Registration Progress

Application Filed
Feb 10, 2022
Under Examination
Approved for Publication
Feb 14, 2023
Published for Opposition
Feb 14, 2023
Registered
May 30, 2023

Trademark Image

SPARCLIFE

Basic Information

Serial Number
97261612
Registration Number
7065692
Filing Date
February 10, 2022
Registration Date
May 30, 2023
Published for Opposition
February 14, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 30, 2023
Registration
Registered
Classes
042

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17/B, Mahal Industrial Estate,
Mahakali Caves Road, Andheri (East)
Mumbai, Maharashtra 400093
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai, Maharashtra IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai, Maharashtra IN

Sun Pharma Advanced Research Company Limited

Original Registrant
16
Mumbai, Maharashtra IN

Legal Representation

Attorney
Nancy A. Del Pizzo

USPTO Deadlines

Next Deadline
1412 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-30)
Due Date
May 30, 2029
Grace Period Ends
November 30, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
May 30, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 30, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 26, 2023 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Feb 22, 2023 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Feb 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 11, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 11, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 11, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 11, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 11, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 3, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 3, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 23, 2022 ALIE A ASSIGNED TO LIE Loading...
Nov 1, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Oct 19, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 19, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Oct 19, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 5, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Oct 5, 2022 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Oct 3, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Oct 3, 2022 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Sep 23, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 23, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 23, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 23, 2022 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Sep 23, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific and technological services, namely, research and design in the field of pharmaceuticals; analysis of industrial fluids; industrial research in the field of formulation and development of pharmaceuticals; industrial design services; quality control of services; authentication services in the field of formulation and development of pharmaceuticals; design and development of computer hardware and software; all of the foregoing excluding services related to gene and cell therapies
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
SUN PHARMA ADVANCED RESEARCH COMPANY LIFE

Classification

International Classes
042